Experts Question Whether FDA, CMS Collaborating On Approvals

By Luke Zarzecki / July 1, 2025 at 2:40 PM

As FDA leadership emphasizes increasing the speed of drug approvals, experts are questioning whether FDA is collaborating on the effort with CMS, which has in the past caused controversy by refusing to fully cover drugs granted FDA accelerated approval.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.